10.1007/s00210-024-03777-2 73 HuT.DongY.HeC.ZhaoM.HeQ
J Clin Endocrinol Metab 80:13931398 Guevara-Aguirre J, Rosenbloom AL, Vasconez O, Martinez V, Gargosky SE, Allen L, Rosenfeld RG (1997) Two year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency
Amongst randomized patients who already lost 5% body weight during the 12-week intensive lifestyle lead-in period, subsequent treatment with ZEPBOUND resulted in a statistically significant reduction in body weight compared to placebo from randomization (Week 0) to Week 72
It does not replace sunscreen, acne care, prescription skincare, medical evaluation, or healthy daily habits